The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Critical Driver Shaping the Global Genotyping Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Genotyping Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Having observed substantial recent expansion, the market dedicated to genotyping is projected to ascend from a valuation of $23.04 billion in the year 2024 to $26.55 billion by 2025, reflecting a compound annual growth rate (CAGR) of 15.3%; this historical upward trajectory is underpinned by several key factors: governmental support and allocated funding, a noticeable decrease in the expenses associated with genotyping procedures, the broadening scope of biobanks and comprehensive genetic repositories, a rising incidence of hereditary conditions, and advancements within pharmacogenomics and pharmaceutical research and development.

Genotyping Market Size Forecast: What's the Projected Valuation by 2029?
Anticipation suggests the genotyping sector will experience accelerated expansion over the forthcoming years, projected to achieve a valuation of $51.22 billion by 2029, reflecting a compound annual growth rate (CAGR) of 17.8%. This surge in the projection timeframe is fueled by several factors, including the wider uptake within clinical diagnostic procedures, escalating requirements for individualized medical treatments, an uptick in research and development endeavors, and the broadening utility across agricultural and animal husbandry sectors. Key developments characterizing this period involve the increasing need for pharmacogenomics, progressive leaps in next-generation sequencing (NGS) technologies, the deepening involvement in precision medicine programs, the proliferation of direct-to-consumer (DTC) genetic testing options, and concentrated efforts in the realms of cancer genomics and tailored therapeutic approaches.

View the full report here:
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report

What Are the Drivers Transforming the Genotyping Market?
The increasing incidence of both oncological diseases and inherited conditions is anticipated to stimulate the expansion of the genotyping sector in the near future. Cancer encompasses a wide range of ailments that can originate in nearly any part of the body's organs or tissues, whereas genetic disorders are defined as conditions resulting entirely or in part from an anomaly in the standard DNA sequence. Through genotyping methods, researchers are enabled to examine different genetic differences, including single nucleotide polymorphisms, variations in copy number, and significant alterations to the DNA's structure. This process, termed genetic testing or genotyping, is employed to search for particular alterations in genes that might increase an individual's susceptibility to developing certain cancers. To illustrate the scale of the issue, the World Health Organization, a specialized international public health body situated in Switzerland, reported in February 2024 that around 20 million new instances of cancer were documented in 2022, leading to 9.7 million fatalities, with an estimated 53.5 million people surviving five years post-diagnosis that same year. Concurrently, Gene People UK, an officially registered charity in the United Kingdom, estimated in February 2023 that one in every twenty-five children currently lives with a condition passed down through heredity, translating to roughly 30,000 new diagnoses among infants and children annually within the UK, and affecting over 2.4 million children and adults overall. Consequently, the rising rates of cancer and genetic disorders serve as a primary catalyst for the onward progression of the genotyping market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp

What Long-Term Trends Will Define the Future of the Genotyping Market?
A significant current in the genotyping industry involves the emergence of novel product developments, compelling entities within this space to integrate inventive approaches to preserve their competitive standing. As an illustration, in May of 2022, Neogen, an American firm specializing in food safety, collaborated with Gencove Inc., a U.S. vendor of a genome discovery sequencing platform, to introduce InfiniSEEK. This new offering represents an inventive yet budget-conscious methodology for sequencing entire genomes alongside specific SNP assessments, uniquely serving as the inaugural comprehensive sequencing platform for both whole-genome analysis and genotyping tailored for bovine breeders. Through the deployment of InfiniSEEK, the sector is now equipped with a dependable system capable of overseeing upwards of 400 bovine genetic attributes and conditions, enabling the identification of previously unknown factors influencing favorable traits, and mitigating selection skew by sequencing a greater portion, ideally the entirety, of the population. This distinct service availability furnishes clients with an economically viable, data-dense means to profile cattle globally by synthesizing comprehensive genome-wide sequencing information with particular genetic markers and parentage indicators.

Which Segments in the Genotyping Market Offer the Most Profit Potential?
The genotypingmarket covered in this report is segmented -

1) By Product And Services: Instruments; Reagents And Kits; Bioinformatics; Genotyping Service
2) By Technology: Microarrays; Capillary Electrophoresis; Sequencing; Polymerase Chain Reaction; Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry; Other Technologies
3) By Application: Pharmacogenomics; Diagnostics And Personalized Medicine; Animal Genetics; Agricultural Biotechnology; Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies; Diagnostics And Research Laboratories; Academic Institutes; Other End-Users

Subsegments:
1) By Instruments: Sequencers; PCR Machines; Microarrays; Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software; Genomic Data Management Tools; Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services; Custom Genotyping Services; Sample Preparation Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp

Which Firms Dominate the Genotyping Market by Market Share and Revenue in 2025?
Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics

Which Regions Offer the Highest Growth Potential in the Genotyping Market?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.